Navigation Links
Free drug samples influence prescribing, say one in three doctors

One in three doctors agree that free drug samples influence prescribing, finds a small but representative US survey published in the Journal of Medical Ethics.

But they also think that other doctors are more likely to be influenced by incentives than they are, the data show.

In March 2003, the research team surveyed 397 members of the American College of Obstetricians and Gynecologists about their relationships with the pharmaceutical industry.

The members were part of a collaborative research network, representing each of the 10 districts covered by the College.

Just over half of those surveyed responded (217).

More than 90% of the respondents thought it was ethical to accept free samples of a new drug from a pharmaceutical company rep.

Similarly, just over half thought it was ethical to accept a lucrative consultancy with a company if they were a "high volume" prescriber of one of that company's drugs.

One in three agreed that their decision to prescribe a drug would probably be influenced by accepting the samples.

But respondents felt that other doctors would be significantly more likely to accept the offer of a free lunch, an anatomical model emblazoned with a drug's name, or a consultancy than they would, even if offered without free samples.

And they also felt that these free "gifts" would still influence the other doctors' prescribing decisions more than it would theirs.

Most doctors said they distributed the free drug samples to their patients to help them out financially or for their convenience. Less than two thirds did so because they felt the drug in question was particularly effective.

Almost two thirds of the respondents were aware of professional guidelines on the relationship between industry and the profession

But only one in three felt that the relationship should be more tightly regulated. Two fifths felt that it should not be restricted fu rther.

"The generally held view that accepting modest incentive items, such as drug samples is appropriate and primarily of benefit to patients needs to be reconsidered, both by doctors and by policy makers," say the authors. Guidelines need to do more to challenge this view, they add.
'"/>

Source:BMJ Specialty Journals


Related biology news :

1. Study reveals new technique for fingerprinting environmental samples
2. Bird samples from Mongolia confirmed as H5N1 avian flu
3. Ocean virus identified in human blood samples
4. Hair samples show babies can be exposed to crystal meth while in the womb
5. Fighting influenza & co. with 40,000 blood samples
6. Childrens taste sensitivity and food choices influenced by taste gene
7. Viral protein influences key cell-signaling pathway
8. Structure-building cell signals also may influence learning and memory
9. NIH renews network focused on how genes influence drug responses
10. Toasty oat aroma influenced by presence of health-linked polyphenols
11. Phenotype is influenced by nature, nurture and noise

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/31/2017)... Mass. , Jan. 31, 2017  Spero ... novel therapies for the treatment of bacterial infections, ... set of antibacterial candidates from Pro Bono Bio ... increased prevalence of multi-drug resistant forms of Gram-negative ... Cantab Anti Infectives Ltd, a PBB group company. ...
(Date:1/26/2017)... , Jan. 26, 2017  Acuity Market ... for Biometrics and Digital Identity".  Acuity characterizes 2017 ... identity when increased adoption reflects a new understanding ... "Biometrics and digital identity are often ... Maxine Most , Principal of Acuity Market ...
(Date:1/24/2017)... 2017  It sounds simple and harmless—an electronic ... vital signs and alerts parents on their smart ... level drops. But pediatric experts argue that such ... no evidence of medical benefits, especially to healthy ... to parents of healthy babies, promising peace of ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... and SAN FRANCISCO , Feb. ... regenerative medicine company, and Beyond Type 1, a not-for-profit ... 1 diabetes, today announced a grant from Beyond Type ... cure for type 1 and other insulin-requiring diabetes.  ... been developing innovative stem cell-derived cell replacement therapies with ...
(Date:2/22/2017)...  PrimeVax Immuno-Oncology, Inc. announced today its CEO, ... Biocom Global Life Science Partnering Conference.  The presentation will ... the Torrey Pines Lodge, in San Diego.  ... who have chosen our company, amongst numerous others, to ... and clinical researchers," said Mr. Chen. "In contrast to ...
(Date:2/22/2017)... ... February 22, 2017 , ... LabRoots , the leading provider of educational ... is pleased to announce the launch of a new scholarship for young scientists seeking ... This merit-based scholarship is open to all high school seniors, 17 years or older; ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... the addition of Tom Perkins as European director. Operating from Pennside’s Zurich headquarters, ... Pennside. , Perkins joins Pennside after more than a decade with leading ...
Breaking Biology Technology: